Modular Medical (Modular Medical) ROCE % : -307.52% (As of Dec. 2023)

View and export this data going back to . Start your Free Trial

What is Modular Medical ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Modular Medical's annualized ROCE % for the quarter that ended in Dec. 2023 was -307.52%.

Modular Medical ROCE % Historical Data

The historical data trend for Modular Medical's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Modular Medical ROCE % Chart

Modular Medical Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

ROCE %

Get a 7-Day Free Trial

-47.75

-109.99

-682.83

-405.75

-183.29

Modular Medical Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
ROCE %	Get a 7-Day Free Trial															-143.14	-199.92	-158.59	-155.16	-307.52

Modular Medical ROCE % Calculation

Modular Medical's annualized ROCE % for the fiscal year that ended in Mar. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Mar. 2023 )		(A: Mar. 2022 )		(A: Mar. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Mar. 2023 )		(A: Mar. 2022 )		(A: Mar. 2023 )
	=	-13.877	/	( ( (9.846 - 0.97)	+	(7.245 - 0.979) )	/ 2 )
	=	-13.877	/	( (8.876	+	6.266)	/ 2 )
	=	-13.877	/	7.571
	=	-183.29 %

Modular Medical's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	-21.076	/	( ( (10.059 - 1.112)	+	(6.199 - 1.439) )	/ 2 )
	=	-21.076	/	( ( 8.947	+	4.76 )	/ 2 )
	=	-21.076	/	6.8535
	=	-307.52 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

Modular Medical (NAS:MODD) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Modular Medical ROCE % Related Terms

Thank you for viewing the detailed overview of Modular Medical's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Modular Medical (Modular Medical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Modular Medical Inc (NAS:MODD) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

10470 Thornmint Road, San Diego, CA, USA, 92127

Website

https://www.modular-medical.com

Modular Medical Inc is a development stage medical device company which focuses on the design, development, and commercialization of an insulin pump using modernized technology to increase pump adoption in the diabetes marketplace. The company's product's seeks to serve both the type 1 and the rapidly growing especially in terms of device adoption, type 2 diabetes markets.

Executives

Philip Brent Sheibley	director	C/O MODULAR MEDICAL, INC., 16772 W. BERNARDO DRIVE, SAN DIEGO CA 92127
Manchester Management Co Llc	10 percent owner	3 WEST HILL PLACE, BOSTON MA 02110
Jeb Partners, L.p.	other: Director by Deputization	MANCHESTER MANAGEMENT COMPANY, L.L.C, 3 WEST HILL PLACE, BOSTON MA 02114
Kevin Schmid	officer: Chief Operating Officer	8 EAGLES NEST LANE, BEDFORD MA 01921
Paul Diperna	director, 10 percent owner, officer: See Remarks	16772 W BERNARDO DRIVE, RANCHO BERNARDO CA 92127
Carmen B Volkart	director	C/O MODULAR MEDICAL, INC., 16772 WEST BERNARDO DRIVE, SAN DIEGO CA 92127
Duane M Desisto	director	INSULET CORPORATION, 9 OAK PARK DRIVE, BEDFORD MA 01730
Ellen O'connor Vos	director	C/O NTELOS HOLDINGS CORP., 1154 SHENANDOAH VILLAGE DRIVE, WAYNESBORO VA 22980
Steven G Felsher	director	C/O SITO MOBILE, LTD.,, 100 TOWN SQUARE PLACE, STE 204, JERSEY CITY NJ 07310
Morgan C. Frank	10 percent owner	2 CALLE NAIRN, UNIT 701, SAN JUAN PR 00907
Paul Diperna Irrevocable Trust	other: See Footnote(1)	16772 WEST BERNARDO DRIVE, SAN DIEGO CA 92127
Stephen Edward Daly	officer: Chief Commercial Officer	2090 DIPINTO ROAD, HENDERSON NV 89052
William J Febbo	director	600 CALIFORNIA ST., 9TH FLOOR, SAN FRANCISCO CA 94108
Liam Burns	director	C/O MODULAR MEDICAL, INC., 800 W. VALLEY PARKWAY, SUITE 203, ESCONDIDO CA 92025
James E Besser	10 percent owner	3 WEST HILL PLACE, BOSTON MA 02114